Cargando…

Cytokine Landscape in Central Nervous System Metastases

The central nervous system is the location of metastases in more than 40% of patients with lung cancer, breast cancer and melanoma. These metastases are associated with one of the poorest prognoses in advanced cancer patients, mainly due to the lack of effective treatments. In this review, we explor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marin, Julie, Journe, Fabrice, Ghanem, Ghanem E., Awada, Ahmad, Kindt, Nadège
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9313120/ https://www.ncbi.nlm.nih.gov/pubmed/35884845 http://dx.doi.org/10.3390/biomedicines10071537

Ejemplares similares

Galectins and Carcinogenesis: Their Role in Head and Neck Carcinomas and Thyroid Carcinomas
por: Kindt, Nadège, et al.
Publicado: (2017)

Role of Macrophage Migration Inhibitory Factor (MIF) in Melanoma
por: Soumoy, Laura, et al.
Publicado: (2019)

RTK Inhibitors in Melanoma: From Bench to Bedside
por: Sabbah, Malak, et al.
Publicado: (2021)

Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance
por: Kehagias, Pashalina, et al.
Publicado: (2022)

PRIMA-1 and PRIMA-1(Met) (APR-246): From Mutant/Wild Type p53 Reactivation to Unexpected Mechanisms Underlying Their Potent Anti-Tumor Effect in Combinatorial Therapies
por: Perdrix, Anne, et al.
Publicado: (2017)

Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma
por: Najem, Ahmad, et al.
Publicado: (2022)

Acquired resistance to BRAFi reverses senescence-like phenotype in mutant BRAF melanoma
por: Krayem, Mohammad, et al.
Publicado: (2018)

Targeting Prohibitins to Inhibit Melanoma Growth and Overcome Resistance to Targeted Therapies
por: Najem, Ahmad, et al.
Publicado: (2023)

The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanoma
por: Sabbah, Malak, et al.
Publicado: (2023)

The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma
por: Krayem, Mohammad, et al.
Publicado: (2019)

Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value
por: Najem, Ahmad, et al.
Publicado: (2021)

Roles of Progesterone, Testosterone and Their Nuclear Receptors in Central Nervous System Myelination and Remyelination
por: Ghoumari, Abdel Mouman, et al.
Publicado: (2020)

Cytokines and Myelination in the Central Nervous System
por: Schmitz, Thomas, et al.
Publicado: (2008)

TYRP1 mRNA expression in melanoma metastases correlates with clinical outcome
por: Journe, F, et al.
Publicado: (2011)

Effect of Oxidized Low-Density Lipoprotein on Head and Neck Squamous Cell Carcinomas
por: Kindt, Nadège, et al.
Publicado: (2021)

The Interplay between Atherosclerosis and Cancer: Breast Cancer Cells Increase the Expression of Endothelial Cell Adhesion Markers
por: Scalia, Alessandro, et al.
Publicado: (2023)

Toad Venom Antiproliferative Activities on Metastatic Melanoma: Bio-Guided Fractionation and Screening of the Compounds of Two Different Venoms
por: Soumoy, Laura, et al.
Publicado: (2020)

Emerging Landscape of Immunotherapy for Primary Central Nervous System Lymphoma
por: Alcantara, Marion, et al.
Publicado: (2021)

Metabolic Reprogramming in Metastatic Melanoma with Acquired Resistance to Targeted Therapies: Integrative Metabolomic and Proteomic Analysis
por: Soumoy, Laura, et al.
Publicado: (2020)

Interleukin-6, a Major Cytokine in the Central Nervous System
por: Erta, María, et al.
Publicado: (2012)

Uterine leiomyosarcoma with central nervous system metastases
por: Abrahão, Carina Meira, et al.
Publicado: (2015)

Advances in the Management of Central Nervous System Metastases from Breast Cancer
por: Avila, Jorge, et al.
Publicado: (2022)

Microglia and metastases to the central nervous system: victim, ravager, or something else?
por: Caffarel, Maria M., et al.
Publicado: (2022)

Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. Cancers 2020, 12, 512
por: Krayem, Mohammad, et al.
Publicado: (2020)

Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma
por: Krayem, Mohamad, et al.
Publicado: (2020)

The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts
por: Id Boufker, Hichame, et al.
Publicado: (2010)

Development of a Method for Producing oxLDL: Characterization of Their Effects on HPV-Positive Head and Neck Cancer Cells
por: Scalia, Alessandro, et al.
Publicado: (2022)

Tyrosinase-related protein 1 mRNA expression in lymph node metastases predicts overall survival in high-risk melanoma patients
por: El Hajj, P, et al.
Publicado: (2013)

Management Paradigm of Central Nervous System Metastases in NSCLC: An Australian Perspective
por: Lee, Chee Khoon, et al.
Publicado: (2023)

Restoring p53 Function in Head and Neck Squamous Cell Carcinoma to Improve Treatments
por: de Bakker, Tycho, et al.
Publicado: (2022)

Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
por: Verfaillie, Annelien, et al.
Publicado: (2015)

Advances in the Management of Central Nervous System Metastases in Non-Small Cell Lung Cancer
por: D’Aiello, Angelica, et al.
Publicado: (2023)

A Toolkit for Profiling the Immune Landscape of Pediatric Central Nervous System Malignancies
por: Rozowsky, Jacob S., et al.
Publicado: (2022)

Extensive systemic metastases from primary central nervous system haemangiopericytoma
por: Ho, Chi Long, et al.
Publicado: (2020)

The genomic and transcriptional landscape of primary central nervous system lymphoma
por: Radke, Josefine, et al.
Publicado: (2022)

Cervical Lymph Node Metastases from Central Nervous System Tumors: A Systematic Review
por: Coca-Pelaz, Andrés, et al.
Publicado: (2022)

Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases
por: Laimito, Katerin Rojas, et al.
Publicado: (2016)

Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications
por: Boire, Adrienne, et al.
Publicado: (2019)

Apoptotic and Non-Apoptotic Modalities of Thymoquinone-Induced Lymphoma Cell Death: Highlight of the Role of Cytosolic Calcium and Necroptosis
por: Berehab, Mimoune, et al.
Publicado: (2021)

Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research
por: Cogels, Morgane M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dhvman2r4kkm2af1vrp4dsn10o